•HRES 476 IH 
Whereas, according to data from the Centers for Disease 
Control and Prevention, fentanyl-related poisonings are 
currently the leading cause of death for individuals in the 
United States between 18 and 49 years of age; 
Whereas naloxone is a safe and effective medication that can 
reverse opioid overdoses and save lives when administered 
promptly by rapidly reversing the effects of opioids; 
Whereas naloxone plays a vital role in preventing long-term 
brain damage and reducing the risk of fatality associated 
with opioid overdoses; 
Whereas the Centers for Disease Control and Prevention has 
declared naloxone to be a key tool in preventing opioid 
overdose deaths; 
Whereas it is imperative to educate individuals, families, 
healthcare professionals, and first responders about— 
(1) the benefits of naloxone, including the potential 
naloxone has to reduce opioid-related fatalities; and 
(2) how to administer naloxone; 
Whereas it is imperative to identify current or potential bar-
riers, including cost, for individuals, organizations, and 
Federal, State, and local governments to obtain and dis-
tribute naloxone; 
Whereas increasing access to naloxone can ensure that indi-
viduals struggling with opioid use disorder have a chance 
at recovery and a future free from the grip of substance 
use disorder; 
Whereas the Food and Drug Administration took action to 
authorize the over-the-counter sale of 4 milligram doses 
of naloxone; and 
Whereas recognizing National Naloxone Awareness Day will 
contribute to the ongoing efforts to educate the public, 
VerDate Sep 11 2014 
04:27 Jun 07, 2023
Jkt 039200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6300
E:\BILLS\HR476.IH
HR476
kjohnson on DSK79L0C42PROD with BILLS
•HRES 476 IH 
reduce stigma associated with substance use disorder, 
and promote access to lifesaving naloxone: Now, there-
fore, be it 
Resolved, That the House of Representatives— 
(1) supports the designation of National 
Naloxone Awareness Day; 
(2) recognizes the life-saving benefits of 
naloxone in reversing opioid overdoses and pre-
venting unnecessary deaths; 
(3) acknowledges that increased access to 
naloxone empowers individuals, families, healthcare 
professionals, and first responders to intervene in 
emergency situations and provide immediate assist-
ance to those experiencing an opioid overdose; 
(4) recognizes that National Naloxone Aware-
ness Day serves as an opportunity to educate mem-
bers of the public about the importance of recog-
nizing the signs of opioid overdose and equipping 
themselves with naloxone to save lives; 
(5) encourages Federal, State, and local govern-
ments, as well as private and nonprofit organiza-
tions, to collaborate and allocate resources toward 
increasing naloxone access, education, and distribu-
tion efforts; and 
(6) calls upon Federal agencies, including the 
Substance Abuse and Mental Health Services Ad-
VerDate Sep 11 2014 
04:27 Jun 07, 2023
Jkt 039200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\HR476.IH
HR476
kjohnson on DSK79L0C42PROD with BILLS
•HRES 476 IH 
ministration, the Centers for Disease Control and 
Prevention, the Office of National Drug Control Pol-
icy, the Drug Enforcement Administration, and all 
other Federal agencies engaged in the National 
Drug Control Strategy of the President to continue 
supporting public awareness, harm reduction, and 
overdose and poisoning prevention. 
Æ 
VerDate Sep 11 2014 
04:27 Jun 07, 2023
Jkt 039200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6301
E:\BILLS\HR476.IH
HR476
kjohnson on DSK79L0C42PROD with BILLS